To investigate whether SOX9 and KLF5 are drivers of cancer stemness, we overexpressed these two transcription factors in vitro using the prostate cancer cell line 22Rv1 and normal prostatic epithelial cell line RWPE‐1. The gene discussed is SOX9; the disease is prostate cancer.